Please use this identifier to cite or link to this item:
|Title:||Magnesium sulfate therapy after cardiac surgery: a before-and-after study comparing strategies involving bolus and continuous infusion.|
|Authors:||Osawa, Eduardo A;Biesenbach, Peter;Cutuli, Salvatore L;Eastwood, Glenn M;Mårtensson, Johan;Matalanis, George;Fairley, Jessica;Bellomo, Rinaldo|
|Affiliation:||Department of Intensive Care, Austin Health, Heidelberg, Victoria, Australia|
Perioperative Medicine and Intensive Care, Karolinska University Hospital, Solna, Sweden
Department of Cardiac Surgery, Austin Health, Heidelberg, Victoria, Australia
School of Public Health and Preventive Medicine, Monash University, Prahran, VIC 3004, Australia
|Citation:||Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 2018; 20(3): 209-216|
|Abstract:||Magnesium therapy may reduce the risk of atrial fibrillation after cardiac surgery. However, studies are heterogeneous in relation to dosage and method of delivery and no studies have directly compared the biochemical effect of different delivery strategies. We conducted a before-and-after study to compare the effects of two strategies of magnesium delivery after cardiac surgery. We conducted a prospective interventional before-and-after study. We enrolled patients admitted to the intensive care unit (ICU) after cardiac surgery and with no history of renal failure. The before period consisted of a single 20 mmol of magnesium sulfate bolus administered over one hour. The after period comprised a 10 mmol magnesium loading dose over one hour followed by a continuous infusion at 3 mmol/h for 12 hours. We measured serum and urine magnesium levels at baseline (T0), at the end of loading dose (T1), 6 (T2) and 12 hours after the intervention (T3). We enrolled 60 patients (30 in each group) with similar baseline characteristics. In the before period, patients had a higher peak serum magnesium level at T1 (1.88 ± 0.06 v 1.59 ± 0.04 mmo/L; P < 0.001) compared with the after period. However, at 6 hours, patients in the after period had a significantly higher magnesium level (1.61 ± 0.04 v 1.29 ± 0.26 mmol/L; P < 0.001) and this level remained higher at 12 hours (1.70 ± 0.05 v 1.17 ± 0.02; P < 0.001), leading to increased time-weighted magnesaemia (P < 0.001). These changes occurred despite a significantly increased urinary magnesium concentration, fractional excretion of magnesium, and magnesium clearance, which paralleled changes in magnesaemia (P < 0.001). The strategy of a 10 mmol magnesium bolus followed by a continuous infusion over 12 hours achieved a more sustained and moderately elevated magnesium concentration in comparison to a single 20 mmol bolus, despite increased urinary losses of magnesium. Further studies are required to assess a more extended continuous infusion.|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.